Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

NEWS

Our Latest News

ARCHIMED buys Premium Global Dental Healthcare US Company ZimVie

ARCHIMED MedTech announces the definitive acquisition of Global Dental Technology Platform, ZimVie, in an approximately $730 million take-private deal.

ARCHIMED  buys Premium Global Dental Healthcare US Company ZimVie

ARCHIMED acquires Irrimax, market leader in anti-microbial wound irrigation solutions

 August

 28, 

2024

Majority owner ARCHIMED and its partners fund three add-on acquisitions by diversified European health safety testing company, CARSO

 May

 6, 

2024

ARCHIMED concludes successfully its £203 million take-private bid for drug development software leader Instem

 November

 27, 

2023

ARCHIMED creates a leading specialized dermatological-focused CRO via the simultaneous purchase & merger of Symbio and Proinnovera

 November

 17, 

2023

ARCHIMED top-ranked buyout fund MED I earns 4.5x on the sale of Vita

 October

 27, 

2023

ARCHIMED Publishes White Paper – “Navigating the FHIR Landscape: A Strategic Approach for Healthcare IT Businesses”

 September

 27, 

2023

< 1 2 3 4 5 6 … 17 >
368
  • ARCHIMED © 2026
  • Our Eco-Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top